David Betts

David Betts is an accomplished professional with over 20 years of experience in the pharmaceutical, biotech, and medical device industries, specializing in quality control operations. Currently, David serves as the Director of Quality Control at BioNTech SE since March 2022. Previous roles include Associate Director of Cell Therapy QC Microbiology at Takeda and Manager of QC Microbiology at Dendreon. David's extensive background encompasses managing quality control systems, overseeing method development, and directing teams in microbiology, cell culture, and bioassay. David holds a Bachelor of Science degree in Microbiology from the University of Arizona.